$LBUY
Leafbuyer Technologies Inc Stock $lbuy

$lbuy Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000147793223003563 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.330M	$1.286M	$984.0K
YoY Change	26.97%	30.7%	46.4%
Cost Of Revenue	$780.0K	$769.7K	$691.3K
YoY Change	6.88%	11.34%	38.04%
Gross Profit	$540.0K	$516.4K	$292.7K
YoY Change	69.94%	76.45%	70.83%
Gross Profit Margin	40.6%	40.15%	29.74%
Selling, General & Admin	$1.620M	$332.3K	$318.8K
YoY Change	-1.15%	4.22%	5.36%
% of Gross Profit	300.0%	64.35%	108.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$180.0K	$181.1K	$181.1K
YoY Change	-0.62%	0.0%	-66.67%
% of Gross Profit	33.33%	35.07%	61.88%
Operating Expenses	$680.0K	$651.5K	$513.5K
YoY Change	8.82%	26.89%	-14.53%
Operating Profit	-$140.0K	-$135.1K	-$220.8K
YoY Change	-54.42%	-38.81%	-48.58%
Interest Expense	-$40.00K	$35.41K	$50.47K
YoY Change	-21.61%	-29.84%	-29.52%
% of Operating Profit
Other Income/Expense, Net	$0.00	$40.00
YoY Change
Pretax Income	-$170.0K	-$170.5K	-$271.3K
YoY Change	-52.54%	-37.16%	-79.04%
Income Tax
% Of Pretax Income
Net Earnings	-$170.0K	-$170.5K	-$271.3K
YoY Change	-52.54%	-37.16%	-79.04%
Net Earnings / Revenue	-12.78%	-13.25%	-27.57%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	95.43M shares	95.43M shares	91.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$450.0K	$434.9K	$429.4K
YoY Change	22.53%	1.28%	-49.17%
Cash & Equivalents	$445.7K	$434.9K	$429.4K
Short-Term Investments
Other Short-Term Assets	$30.00K	$27.38K	$23.26K
YoY Change	29.81%	17.71%	-42.4%
Inventory
Prepaid Expenses
Receivables	$135.5K	$65.01K	$24.70K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$610.5K	$527.3K	$477.4K
YoY Change	45.54%	10.46%	-48.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.225M	$1.406M	$2.131M
YoY Change	-37.16%	-34.0%	141939.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.225M	$1.406M	$2.131M
YoY Change	-37.16%	-34.0%	-25.37%
TOTAL ASSETS
Total Short-Term Assets	$610.5K	$527.3K	$477.4K
Total Long-Term Assets	$1.225M	$1.406M	$2.131M
Total Assets	$1.835M	$1.933M	$2.608M
YoY Change	-22.52%	-25.86%	-30.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$308.8K	$284.1K	$435.9K
YoY Change	-14.43%	-34.83%	129.95%
Accrued Expenses	$1.166M	$1.127M	$994.1K
YoY Change	-1.04%	13.38%	14.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.140M	$1.483M	$1.730M
YoY Change	-34.1%	-14.29%	9.82%
Total Short-Term Liabilities	$2.629M	$2.901M	$3.199M
YoY Change	-19.88%	-9.34%	18.73%
LONG-TERM LIABILITIES
Long-Term Debt	$485.4K	$485.4K	$500.0K
YoY Change	-2.92%	-2.92%	-52.74%
Other Long-Term Liabilities		$0.00
YoY Change
Total Long-Term Liabilities	$485.4K	$485.4K	$500.0K
YoY Change	-2.92%	-2.92%	-52.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.629M	$2.901M	$3.199M
Total Long-Term Liabilities	$485.4K	$485.4K	$500.0K
Total Liabilities	$3.114M	$3.386M	$3.699M
YoY Change	-17.64%	-8.48%	-1.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$24.44M	-$24.27M	-$23.49M
YoY Change	2.45%	3.3%
Common Stock	$99.43K	$95.43K	$91.95K
YoY Change	6.55%	3.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.279M	-$1.452M	-$1.092M
YoY Change
Total Liabilities & Shareholders Equity	$1.835M	$1.933M	$2.608M
YoY Change	-22.52%	-25.86%	-30.91%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$170.0K	-$170.5K	-$271.3K
YoY Change	-52.54%	-37.16%	-79.04%
Depreciation, Depletion And Amortization	$180.0K	$181.1K	$181.1K
YoY Change	-0.62%	0.0%	-66.67%
Cash From Operating Activities	$90.00K	$252.9K	-$22.81K
YoY Change	-244.72%	-1208.51%	-60.19%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-80.00K	-116.2K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	90.00K	252.9K	-22.81K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	-80.00K	-116.2K	0.000
Net Change In Cash	10.00K	136.7K	-22.81K
YoY Change	-116.08%	-699.21%	-112.98%
FREE CASH FLOW
Cash From Operating Activities	$90.00K	$252.9K	-$22.81K
Capital Expenditures	$0.00
Free Cash Flow	$90.00K
YoY Change	-244.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1406145	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1949479	usd
	lbuy	Weighted Average Grant Date Fair Falue Forfeited WeightedAverageGrantDateFairFalueForfeited	0.00
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95428575	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001643721
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95428575	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93316288	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	lbuy	Weighted Average Interest Rate WeightedAverageInterestRate	0.0513	pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-206745
	dei	Entity Registrant Name EntityRegistrantName	LEAFBUYER TECHNOLOGIES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3944821
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6888 S. Clinton Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	235-0099
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	95428575	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	434933	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	367245	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14037	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	65010	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29085	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27383	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23109	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	527326	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	419439	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1406145	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1949479	usd
CY2023Q1	us-gaap	Assets Assets	1933471	usd
CY2022Q2	us-gaap	Assets Assets	2368918	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	284096	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	360936	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1127109	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1178030	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6737	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	12697	usd
CY2023Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	107817	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	325000	usd
CY2023Q1	us-gaap	Debt Current DebtCurrent	1374802	usd
CY2022Q2	us-gaap	Debt Current DebtCurrent	1404802	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2900561	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3281465	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	485378	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	500000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3385939	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3781465	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93316288	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	95428	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	93315	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22718581	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22344293	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24266809	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23850487	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1452468	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1412547	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1933471	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2368918	usd
CY2023Q1	us-gaap	Revenues Revenues	1286132	usd
CY2022Q1	us-gaap	Revenues Revenues	984010	usd
	us-gaap	Revenues Revenues	3763207	usd
	us-gaap	Revenues Revenues	2759532	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	769701	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	691328	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2059325	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1983921	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	516431	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	292682	usd
	us-gaap	Gross Profit GrossProfit	1703882	usd
	us-gaap	Gross Profit GrossProfit	775611	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	177812	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	153161	usd
	us-gaap	Selling Expense SellingExpense	509198	usd
	us-gaap	Selling Expense SellingExpense	595551	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	154487	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	165679	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	543231	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	463925	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	210828	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	216004	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	594672	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	651908	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	108394	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-21375	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	345980	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	362013	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	651521	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	513469	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-289199	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1297786	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	35410	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	50467	usd
	us-gaap	Interest Expense InterestExpense	130544	usd
	us-gaap	Interest Expense InterestExpense	154788	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2208469	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-170458	usd
CY2023Q1	lbuy	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	usd
CY2022Q1	lbuy	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	usd
	lbuy	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	usd
	lbuy	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	557977	usd
CY2023Q1	us-gaap	Other Income OtherIncome	42	usd
CY2022Q1	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	3423	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-271254	usd
	us-gaap	Net Income Loss NetIncomeLoss	-416320	usd
	us-gaap	Net Income Loss NetIncomeLoss	1313872	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95428575	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	255041108	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94788529	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90511052	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146497094	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	253523746	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1412547	usd
	lbuy	Stock Based Compensation For Employees StockBasedCompensationForEmployees	273618	usd
	lbuy	Issuance Of Common Stock For Vendor Payments Amount IssuanceOfCommonStockForVendorPaymentsAmount	30420	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	72362	usd
	us-gaap	Net Income Loss NetIncomeLoss	-416320	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1452468	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-7224121	usd
	lbuy	Stock Based Compensation For Employees StockBasedCompensationForEmployees	226613	usd
	lbuy	Issuance Of Common Stock For Vendor Payments Amount IssuanceOfCommonStockForVendorPaymentsAmount	63854	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	135400	usd
	lbuy	Bifurcated Derivative Ps A BifurcatedDerivativePsA	4392870	usd
	us-gaap	Net Income Loss NetIncomeLoss	1313872	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-1091512	usd
	us-gaap	Profit Loss ProfitLoss	-416320	usd
	us-gaap	Profit Loss ProfitLoss	1313872	usd
	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	345981	usd
	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	362012	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	30420	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	63854	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	2208469	usd
	lbuy	Forgiveness Of Ppp Loans ForgivenessOfPppLoans	0	usd
	lbuy	Forgiveness Of Ppp Loans ForgivenessOfPppLoans	557977	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	543334	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	543334	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	35925	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6779	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4276	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9104	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-76840	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	222442	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-56881	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8060	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	329493	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-255197	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	261805	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-261805	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	lbuy	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effects CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffects	-67688	usd
	lbuy	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effects CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffects	-255197	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367245	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	684639	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	434933	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	429442	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	lbuy	Issuance Of Common Stock For Vendor Payments IssuanceOfCommonStockForVendorPayments	30420	usd
	lbuy	Issuance Of Common Stock For Vendor Payments IssuanceOfCommonStockForVendorPayments	223000	usd
CY2023Q1	us-gaap	Cash Cash	434933	usd
CY2023Q1	lbuy	Working Capital Deficit WorkingCapitalDeficit	-2373235	usd
	lbuy	Net Loss NetLoss	-24266809	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	416322	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management uses estimates and assumptions in preparing these condensed consolidated financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Examples of estimates include loss contingencies; useful lives of our tangible and intangible assets; allowances for doubtful accounts; and stock-based compensation forfeiture rates. Examples of assumptions include: the elements comprising a software arrangement, including the distinction between upgrades or enhancements and new products; when technological feasibility is achieved for our products; the potential outcome of future tax consequences of events that have been recognized in our financial statements or tax returns. Actual results could differ from those estimates.</p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior period amounts have been reclassified to conform with the current period presentation.</p>
CY2022Q1	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	29119898	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3645494	shares
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	10472193	shares
CY2022Q1	lbuy	Series A Convertible Preferred Stock SeriesAConvertiblePreferredStock	210286161	shares
CY2023Q1	lbuy	Software Platform SoftwarePlatform	4482225	usd
CY2022Q2	lbuy	Software Platform SoftwarePlatform	4482225	usd
CY2023Q1	lbuy	Furniture And Fixtures FurnitureAndFixtures	1500	usd
CY2022Q2	lbuy	Furniture And Fixtures FurnitureAndFixtures	1500	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2534246	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	543334	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	543334	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	724445	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	681700	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	1406145	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	lbuy	Increase In Common Shares IncreaseInCommonShares	150000000	usd
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	lbuy	Derivative Liability DerivativeLiability	4392870	usd
CY2020	lbuy	Increase In Common Shares IncreaseInCommonShares	838303	usd
CY2022Q1	lbuy	Total Unpaid Principal Balance TotalUnpaidPrincipalBalance	242416	usd
CY2019	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	533000	usd
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	402000	usd
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	131000	usd
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4000000	usd
CY2022Q4	lbuy	Remaining Principal Amount F0 RemainingPrincipalAmountF0	30000	usd
CY2019	lbuy	Remaining Principal Amount RemainingPrincipalAmount	214802	usd
CY2019Q2	lbuy	Total Unpaid Principal Balance TotalUnpaidPrincipalBalance	347262	usd
CY2020	lbuy	Promissory Note Default Amount PromissoryNoteDefaultAmount	100000	usd
	lbuy	Promissory Note Default Amount PromissoryNoteDefaultAmount	7817	usd
CY2020Q2	lbuy	Total Unpaid Principal Balance TotalUnpaidPrincipalBalance	12823	usd
CY2020Q2	lbuy	Edil Loan Amount EDILLoanAmount	500000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	130705	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	154787	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	680183	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	501423	usd
	lbuy	Weighted Average Interest Rate WeightedAverageInterestRate	0.064	pure
	lbuy	Weighted Average Interest Rate WeightedAverageInterestRate	0.0513	pure
CY2023Q1	lbuy	Less Current Portion Of Notes Payables LessCurrentPortionOfNotesPayables	1482619	usd
CY2022Q2	lbuy	Less Current Portion Of Notes Payables LessCurrentPortionOfNotesPayables	1729802	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	485378	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	500000	usd
	lbuy	Options Nonvested Beginning Balance OptionsNonvestedBeginningBalance	13450170	shares
	lbuy	Weighted Average Grant Date Fair Falue Nonvested Beginning WeightedAverageGrantDateFairFalueNonvestedBeginning	0.08
	lbuy	Options Granted OptionsGranted	2500000	shares
	lbuy	Weighted Average Grant Date Fair Falue Granted WeightedAverageGrantDateFairFalueGranted	0.04
	lbuy	Options Vested OptionsVested	-1055670	usd
	lbuy	Weighted Average Grant Date Fair Falue Vested WeightedAverageGrantDateFairFalueVested	0.08
	lbuy	Options Nonvested Ending Balance OptionsNonvestedEndingBalance	14894500	shares
	lbuy	Weighted Average Grant Date Fair Falue Nonvested Ending WeightedAverageGrantDateFairFalueNonvestedEnding	0.05
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	29119898	shares
CY2023Q1	lbuy	Aggregate Intrinsic Value AggregateIntrinsicValue	0	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	54403	usd

Files In Submission

Name	View Source	Status
lbuy-20230331_cal.xml	Edgar Link	unprocessable
lbuy-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lbuy-20230331_def.xml	Edgar Link	unprocessable
0001477932-23-003563-index-headers.html	Edgar Link	pending
0001477932-23-003563-index.html	Edgar Link	pending
0001477932-23-003563.txt	Edgar Link	pending
0001477932-23-003563-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lbuy-20230331.xsd	Edgar Link	pending
lbuy_10q.htm	Edgar Link	pending
lbuy_ex311.htm	Edgar Link	pending
lbuy_ex312.htm	Edgar Link	pending
lbuy_ex321.htm	Edgar Link	pending
lbuy_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
lbuy-20230331_pre.xml	Edgar Link	unprocessable
lbuy_10q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LBUY
Leafbuyer Technologies Inc Stock $lbuy

2023 Q2 Form 10-Q Financial Statement

#000147793223003563 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBUY Leafbuyer Technologies Inc Stock $lbuy

2023 Q2 Form 10-Q Financial Statement

#000147793223003563 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBUY
Leafbuyer Technologies Inc Stock $lbuy